SARS-CoV-2 (variant) detection solutions with the NextGenPCR®
NextGenPCR® has developed two unique solutions for SARS-CoV-2 detection and variant surveillance. Our fluorescence probe based screening solution enables you to determine an active SARS-CoV-2 infection directly from a clinical sample within 27 minutes. With the NextGenPCR® variant nanopore sequencing solution you can achieve ultrafast viral genotyping and increase the speed of your nanopore workflow up to 4 times. Find more information below.